Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Charles River Laboratories International, Inc. CRL | Wellington Management Group LLP | 4,285,012 8.400% | 544,244 (+14.55%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 3,524,401 6.900% | -714,096 (-16.85%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,238,497 8.200% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL | Wellington Management Group LLP | 3,740,768 7.250% | 2,660,989 (+246.44%) | Filing History |
| 2024-10-22 3:24 pm Sale | 2024-09-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,238,497 8.200% | -956,589 (-18.41%) | Filing History |
| 2024-02-13 5:01 pm Purchase | 2023-12-29 | 13G | Charles River Laboratories International, Inc. CRL | The Vanguard Group | 5,980,236 11.660% | 23,276 (+0.39%) | Filing History |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,195,086 10.100% | -23,666 (-0.45%) | Filing History |
| 2023-07-07 4:37 pm Purchase | 2023-06-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,218,752 10.200% | 237,607 (+4.77%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Charles River Laboratories International, Inc. CRL | The Vanguard Group | 5,956,960 11.710% | 87,835 (+1.50%) | Filing History |
| 2023-01-31 09:04 am Sale | 2023-01-31 | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 557,203 1.095% | -2,212,925 (-79.89%) | Filing History |
| 2023-01-24 1:56 pm Sale | 2022-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 4,981,145 9.800% | -98,881 (-1.95%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL | The Vanguard Group | 5,869,125 11.630% | 841,221 (+16.73%) | Filing History |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Charles River Laboratories International, Inc. CRL | FMR LLC | 2,770,128 5.489% | 963,419 (+53.32%) | Filing History |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,080,026 10.100% | -289,587 (-5.39%) | Filing History |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL | The Vanguard Group | 5,027,904 10.110% | -291,472 (-5.48%) | Filing History |
| 2021-01-26 6:52 pm Purchase | 2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,369,613 10.800% | 28,230 (+0.53%) | Filing History |
| 2020-07-10 10:39 am Purchase | 2020-06-30 | 13G | Charles River Laboratories International, Inc. CRL | BlackRock Inc. BLK | 5,341,383 10.800% | 847,430 (+18.86%) | Filing History |